PharmaCyte Biotech (PMCB) Return on Assets (2011 - 2026)
PharmaCyte Biotech (PMCB) posted quarterly Return on Assets of 0.0% for Q2 2026, little changed year-over-year from 0.0% in Q2 2025, and down 40.86% quarter-over-quarter from 0.0% in Q1 2026.
PharmaCyte Biotech (PMCB) Return on Assets (2011 - 2026) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported Return on Assets for 16 consecutive years, with 0.0% the latest figure, recorded in Q2 2026.
- In Q2 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Apr 2026 stood at 0.0% (changed 0.0% YoY), while the FY2026 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Assets fell to 0.0% in Q2 2026 per PMCB's latest filing, from 0.0% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q4 2023 and bottomed at 0.0% in Q2 2026.
- Historically, Return on Assets has averaged 0.0% across 5 years, with a median of 0.0% in 2023.
- On a YoY basis, Return on Assets climbed as much as 0 bps in 2022 and fell as far as 0 bps in 2022.
- PharmaCyte Biotech's Return on Assets stood at 0.0% in 2022, then jumped by 47 bps to 0.0% in 2023, then sank by 805 bps to 0.0% in 2024, then declined by 15 bps to 0.0% in 2025, then plunged by 35 bps to 0.0% in 2026.
- Business Quant data shows PMCB's Return on Assets at 0.0% in Q2 2026, 0.0% in Q1 2026, and 0.0% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.77 Bn | 131.91 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.36 Bn | 60.17 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.60 Bn | 54.47 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.13 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 0.00% |
| 10 | PharmaCyte Biotech | 4.44 Mn | 4.44 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 0.00% |
| Jan 31, 2026 | 0.00% |
| Oct 31, 2025 | 0.00% |
| Jul 31, 2025 | 0.00% |
| Apr 30, 2025 | 0.00% |
| Jan 31, 2025 | 0.00% |
| Oct 31, 2024 | 0.00% |
| Jul 31, 2024 | 0.00% |
| Apr 30, 2024 | 0.00% |
| Jan 31, 2024 | 0.00% |
| Oct 31, 2023 | 0.00% |
| Jul 31, 2023 | 0.00% |
| Apr 30, 2023 | 0.00% |
| Jan 31, 2023 | 0.00% |
| Oct 31, 2022 | 0.00% |
| Jul 31, 2022 | 0.00% |
| Apr 30, 2022 | 0.00% |
| Jan 31, 2022 | 0.00% |
| Oct 31, 2021 | 0.00% |
| Jul 31, 2021 | -0.01% |